"Hey man, am I driving okay?"
"I think we're parked, man."
Cheech and Chong in “Up in Smoke” (1978)
Users keep reporting that some cannabis strains tend to make them stoned. The metaphor stands for a strongly relaxing and sedating effect: you get tired and have little energy left for physical activity.
On the other hand, users report that other strains tend to trigger a mental high that does not cause tiredness or physical relaxation and may even give them a boost of energy that lets them get on with physical activities. The “stoned” feeling is stereotypically attributed to indica strains, while the mental “high” is attributed to sativas.
So is it enough to go by the indica and sativa labels when choosing a strain, depending on whether you want to be stoned or high?
Indica, sativa, ruderalis: what is behind the terms?
To answer this question, let us first take a closer look at the labels “indica” and “sativa”. In the past, most botanists divided cannabis into two or three species:
· Cannabis sativa, originally from regions near the equator such as Thailand, Mexico or Jamaica.
· Cannabis indica: from regions such as Afghanistan, India or Nepal.
· Cannabis ruderalis: originally from Central Asia and Eastern Europe, with very little THC. Ruderalis strains are mostly crossed with other genetics to breed so-called “autoflowering” strains. Ruderalis starts flowering regardless of the annual light cycle, which makes it particularly easy to grow indoors. Some botanists, however, have long regarded Cannabis ruderalis as merely a “subspecies” of cannabis.
Today botanists describe cannabis as a single species, Cannabis sativa L., with proposed subspecies and, below those, several varieties. According to John McPartland and Ernest Small, for example, indica and sativa strains would be varieties. For us, though, this reclassification does not matter much, because even as varieties, indica or sativa strains could have specific effect properties as described above.
Why the indica/sativa distinction means little today
Decades of prohibition and the black market have led breeders worldwide to create countless hybrid strains. These were bred specifically for traits such as a short flowering time, high yield and discreet growth, which has resulted in a massive mixing of genetics. Scientists such as Dr Ethan Russo and Dr John M. McPartland therefore criticise that the terms “indica” and “sativa” are hardly reliable today for predicting the actual effect of a strain.
So-called landraces (original, locally adapted strains) have also almost disappeared worldwide: even in remote regions, you now mostly find hybrids with Dutch genetics.
So why do even large cannabis seed banks still classify their genetics as “sativa” and “indica” and make statements like “70% sativa” to explain certain effect properties? Some time ago I spoke with a content manager at a cannabis company who was well aware of the problem and put it very plainly: “Buyers google ‘indica’ or ‘sativa’ when they look for seeds. If we drop the classification, we simply lose a huge number of customers and sales!”
Synergistic effects
So we need to look at the composition of individual strains if we want to know whether they are sedating or not. We know that besides more than 140 cannabinoids, cannabis also contains around 200 terpenes, over 20 flavonoids and other substances that may act synergistically (see the article “How plant compounds work together”). Different cannabis strains contain very different amounts of these substances, which suggests that some of them, in combination with THC or CBD, lead to sedating or other effects.
There are already some candidates for which preclinical studies and user reports point to rather sedating and calming effects, above all the terpenes myrcene (more sedating in synergy with THC) and linalool (studied for calming effects). These terpenes also tend to occur in higher amounts in classic pure indica landraces (before heavy hybridisation).
Neurologist and cannabis expert Ethan Russo describes myrcene as the dominant terpene in many cannabis strains and points to studies on its sedating, muscle-relaxing and sleep-promoting properties. He also notes that myrcene could increase the permeability of the blood-brain barrier and thus enhance the effect of THC. Russo also believes that a terpene such as alpha-pinene could lead to greater alertness and better memory.
Many users report that aged or strongly heated cannabis tends to produce more of a “stoned” effect. Many have assumed that the THC breakdown product cannabinol (CBN) could be responsible, which Ethan Russo also considers possible. Even though CBN is not sedating on its own, it could have a sedating effect in synergy with THC. According to Russo, however, it could also be that the monoterpenoids in aged cannabis have evaporated, leaving behind the more sedating oxygenated sesquiterpenoids.
Biphasic effects
Biphasic effects of THC and CBD also play a central role in how cannabis affects each person. This means the effect can go in opposite directions depending on the dose: low doses of THC are often described as stimulating and mood-lifting, while higher doses can lead to sedation, anxiety or paranoia. Similarly, there are indications that CBD may also be more activating at low doses but calming at higher doses.
Individual effects: genetics and other factors
Cannabis affects people very differently, which can be explained by several factors. First, genetic variants, especially in the endocannabinoid system, influence how strongly and in what way people respond to cannabis. Women are often more sensitive to THC and experience stronger psychoactive effects at lower doses; studies also see stronger effects on pain perception in women, which is attributed to hormonal influences. Other factors also play a role in explaining the individual effect of cannabis, such as (mind)set and setting, meaning mood and personality as well as the context of use, and the build-up of tolerance.
Practical tips
So how can I influence whether a particular cannabis strain makes me more “stoned” or “high”?
· Going by labels like sativa/indica when choosing a strain no longer makes sense for this.
· As a working hypothesis, it makes sense to look at the strain's terpene profile and check the levels of the terpenes myrcene or linalool.
· Breakdown products of THC or CBD, which form for example at high heat or in old products, are suspected of having a sedating effect in synergy with THC. If you do not want to get tired, it is best to choose products and methods of consumption that do not involve too much heat.
· Take companies' statements about experiences with the genetics of well-known strains with a grain of salt. There is still a lot of variation and little standardisation on the market. Companies like HEIMAT that grow cannabis themselves in a regulated and legal context can give more reliable information about their strains.
· Dosage plays a central role, as THC and CBD have biphasic effects; here too it pays to experiment for yourself to get the best results. Start low, go slow: increase the dose gradually.
· Since the effect of a strain also depends on your own genetic make-up and other factors, experiment with different strains yourself to see how a particular strain affects your body.
· Keep a consumption diary: note the strain, dose, method of consumption and effect to spot patterns and fine-tune your experiences.
· Avoid mixing: using cannabis at the same time as alcohol or other substances can change the effect unpredictably and increase risks.
· Store cannabis properly: keep cannabis products cool, dark and airtight.
Conclusion
Choosing the right cannabis strain is more complex than the distinction between indica and sativa suggests. What matters more is a look at the individual terpene and cannabinoid profile as well as personal factors such as genetics, dosage and setting. If you approach it mindfully and with a willingness to experiment, you can find the strain and use that suit you. In the end, an informed, reflective approach is the key to a positive and safe cannabis experience.
Note: The information presented here is for educational purposes only and does not constitute medical advice. For the treatment of illnesses, please consult a healthcare professional.
Sources
1. André, R., Gomes, A. P., & Pereira-Leite, C. (2024). The Entourage Effect in Cannabis Medicinal Products: A Comprehensive Review. Pharmaceuticals (Basel), 17(11), 1543. https://doi.org/10.3390/ph17111543
2. Christensen, C., Rose, M., Cornett, C., & Sufka, K. J. (2023). Decoding the Postulated Entourage Effect of Medicinal Cannabis: What It Is and What It Isn't. Biomedicines, 11(8), 2323. https://doi.org/10.3390/biomedicines11082323
3. Colizzi, M., & Bhattacharyya, S. (2018). Cannabis use and the development of tolerance: A systematic review of human evidence. Neuroscience & Biobehavioral Reviews, 93, 1-25. https://doi.org/10.1016/j.neubiorev.2018.06.012
4. Cooper, Z. D., & Craft, R. M. (2018). Sex differences in cannabinoid pharmacology: A reflection of differences in the endocannabinoid system? British Journal of Pharmacology, 175(14), 3139-3149. https://doi.org/10.1111/bph.14134
5. Hartogsohn, I. (2017). Constructing drug effects: A history of set and setting. Drug Science, Policy and Law, 3, 1-17. https://doi.org/10.1177/2050324516683325
6. Hillig, K. W., & Mahlberg, P. G. (2004). A chemotaxonomic analysis of cannabinoid variation in Cannabis (Cannabaceae). American Journal of Botany, 91(6), 966-975.
7. Marincolo, S. (2021). Die Kunst des Highs. Wie wir mit Cannabis unser Bewusstsein bereichern können. Tredition Verlag.
8. McPartland, J. M., Guy, G. W., & Hegman, W. (2019). Cannabis taxonomy: The "Sativa" and "Indica" debate. In G. W. Guy, B. A. Whittle, & P. Robson (Eds.), The Medicinal Uses of Cannabis and Cannabinoids (pp. 145-161). Pharmaceutical Press.
9. McPartland, J. M., & Small, E. (2020). A classification of endangered high-THC cannabis (Cannabis sativa subsp. indica) domesticates and their wild relatives. PhytoKeys, 144, 81-112. https://doi.org/10.3897/phytokeys.144.46700
10. Russo, E. B. (2011). Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. British Journal of Pharmacology, 163(7), 1344-1364. https://doi.org/10.1111/j.1476-5381.2011.01238.x
11. Russo, E. B., & Marcu, J. (2017). Cannabis pharmacology: The usual suspects and a few promising leads. Advances in Pharmacology, 80, 67-134. https://doi.org/10.1016/bs.apha.2017.03.004
12. Small, E., & Cronquist, A. (1976). A practical and natural taxonomy for Cannabis. Taxon, 25(4), 405-435.